World-class
Scientific Advisory

Work with Richmond Pharmacology and trust your experience will be personal and truly strategic.

What makes us special?Mission statementMeet the expertsBrochuresWebsitesVideosCase StudiesCareers
Meet the Experts //Dilshat Djumanov

Dilshat Djumanov MPhil, PhD
Director of Data Science

Dilshat has an in depth knowledge of data management and data analysis for adaptive clinical trials and QTc studies. Dilshat has a background in IT and demonstrable knowledge of process automation and improvement.

Having worked at Richmond Pharmacology for 14 years, he has led pioneering software development projects which have ensured Richmond Pharmacology’s data management and other processes are efficient, transparent and fast.

Dilshat’s experience is backed by his academic achievements, including a MSc in Computer Sciences, a MPhil in Medical Engineering and a PhD in Computational Fluid Dynamics.  

Back to experts
More about usAdaptive Phase I, II & IIIBridging StudiesTQT StudiesPatient Recruitment

Meet the experts

Richmond Pharmacology has a team of experts with extensive knowledge of clinical research trials.

Latest Publications

View our latest peer-reviewed publications from a selection of our clinical trials.

Latest Videos

Learn more about Richmond Pharmacology by viewing some of our videos.

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more

A new era for UK-Japanese scientific relations

March 23, 2021
Dr Taubel uses his experience of conducting more than 60 Japanese bridging studies to explain why the deal is of strategic importance to the UK and highlights the scientific requirements for conducting successful Japanese trials abroad
Read more

Richmond Pharmacology’s local MP Neil Coyle calls on the Government to evaluate the potential of using Clinical Research Organisations.

February 3, 2021
Richmond Pharmacology has offered its services to the Government and the NHS as an additional vaccine site in London
Read more
© 2021 Richmond Pharmacology
EventsDisclaimerWebsitesSitemapPrivacy
Website by WOD.agency